Spinal Restoration, Inc. Completes Patient Enrollment in Its Pilot Study of the Biostat® Disc Augmentation System for the Treatment of Discogenic Low Back Pain  
9/9/2008 8:52:30 AM

AUSTIN, Texas--(BUSINESS WIRE)--Spinal Restoration, Inc. announced today it has completed enrollment in the Investigational Device Exemption (IDE) pilot study of the Biostat® Disc Augmentation System. Six month clinical results from this three site, 15 patient study are expected to be available in early 2009.